Abstract
3065 Background: Dosing of anticancer agents using body-surface-area (BSA) normalization has been standard clinical practice for most i.v. drugs and continues to be practiced without clear biologic...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
